Data / Form D filings / CORNERSTONE PHARMACEUTICALS INC
CORNERSTONE PHARMACEUTICALS INC: Form D filings
CORNERSTONE PHARMACEUTICALS INC, a pharmaceuticals company in Cranbury,, NJ, filed 4 Form D notices with the SEC between 2010 and 2014. The latest, on March 7, 2014, reports $3.3 million sold of a $7.5 million offering to 1 investor.
Find out what CORNERSTONE PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE DUNCAN DRIVE, Cranbury,, NJ, 08512
- Phone
- (609) 409-7050
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1166509
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 7, 2014 | New notice | $7,500,000 | $3,311,000 | $4,189,000 | 1 | Feb 20, 2014 | sec.gov |
| Mar 29, 2013 | Amendment | $6,000,000 | $4,565,110 | $1,434,890 | 25 | Feb 26, 2013 | sec.gov |
| Mar 13, 2013 | New notice | $6,000,000 | $3,768,100 | $2,231,900 | 16 | Feb 26, 2013 | sec.gov |
| Jan 29, 2010 | New notice | $6,175,750 | $6,175,750 | $0 | 66 | Dec 28, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick S. Wilmerding | Director | |
| Howard S. Jonas | Director | |
| Joseph A. Stern | Director | |
| Robert Shorr | Executive Officer, Director | |
| Aaron Gilbert Drillick | Director | |
| Sim S. Fass | Director | |
| David A. Polinsky | Executive Officer, Director | |
| Herman Gilbert Polinsky | Director | |
| Robert Rodriguez | Executive Officer, Director | |
| Clifford H Straub | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Mar 3, 2014 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CORNERSTONE PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.